Health Condition 1: H259- Unspecified age-related cataract
Conditions
Interventions
Intervention1: Neelanjana Mai: Siddha Collyrium Neelanjana Mai for the management of Senile cataract
Control Intervention1: Placebo: Placebo similar to siddha drug neelanjana mai in colour odour and c
Sponsors
Central Council for Research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both sexes who meet the diagnostic standards of Vellai Patalam Senile Cataract aged between forty and eighty years will be included in this study Participants must be diagnosed with cataracts by Slit Lamp Microscopy of any type including Nuclear Cortical or Posterior Subcapsular Cataract within a grading of less than or equal to Grade Two
Exclusion criteria
Exclusion criteria: Patients suffering from congenital cataracts hypermature cataract glaucoma diabetic retinopathy macular degeneration or retinitis pigmentosa Patients whose random blood sugar levels and blood pressure are not within normal limits Patients who are under steroid treatment any form of immunosuppressive therapy or taking any cataract inducing medication Patients with a grading of more than Grade Two under Slit Lamp Microscopy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The grading of Cataract will be assessed by the Slit lamp examination and Opthalmoscopic examination. The improvement in the Visual acuity will be assessed by the Snellen s chart.Timepoint: At 0 day 45th day and 90th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Acuity (VA), Intraocular Pressure (IOP), Adverse Events (AEs), and blurring of vision, polyopia, nyctalopia, hemeralopia, glaring of light, colored halos, visualization of non-existing things were assessed with the help of grading pattern will be assessed to evaluate the safety of the study drug.Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDrRThilagavathi
Central Council for Research in Siddha
Outcome results
None listed